[Pathophysiology and treatment of thrombosis. 3. Prevention and treatment of thrombosis. (1) The role of intracoronary thrombi, platelet function and prostaglandins in the pathogenesis of myocardial infarction; with special reference to intracoronary thrombolysis treatment].
D003327:Coronary Disease / Q000188:drug therapy*; D003328:Coronary Thrombosis / Q000188:drug therapy* / Q000517:prevention & control; D011464:Epoprostenol / Q000502:physiology*; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D010974:Platelet Aggregation; D013928:Thromboxane A2 / Q000502:physiology*; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*
D013928:Thromboxane A2; D011464:Epoprostenol; D014568:Urokinase-Type Plasminogen Activator